Document Detail

Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity.
MedLine Citation:
PMID:  16107159     Owner:  NLM     Status:  MEDLINE    
The design and synthesis of a novel class of 2,3-dihydrobenzofuran-2-carboxylic acids as highly potent and subtype-selective PPARalpha agonists are reported. Systematic study of structure-activity relationships has identified several key structural elements within this class for maintaining the potency and subtype selectivity. Select compounds were evaluated in animal models of dyslipidemia using Syrian hamsters and male Beagle dogs, and all these compounds displayed excellent cholesterol- and triglyceride-lowering activity at dose levels that were much lower than the marketed weak PPARalpha agonist fenofibrate.
Guo Q Shi; James F Dropinski; Yong Zhang; Conrad Santini; Soumya P Sahoo; Joel P Berger; Karen L Macnaul; Gaochao Zhou; Arun Agrawal; Raul Alvaro; Tian-Quan Cai; Melba Hernandez; Samuel D Wright; David E Moller; James V Heck; Peter T Meinke
Related Documents :
2126749 - Studies on antibacterial agents. ii. synthesis and antibacterial activities of substitu...
9089339 - Effect of n9-methylation and bridge atom variation on the activity of 5-substituted 2,4...
16875829 - Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid der...
25045889 - Antioxidant, antimicrobial and phytochemical variations in thirteen moringa oleifera la...
12769 - Synthetic analgesics: n-(1-[2-arylethyl]-4-substituted 4-piperidinyl) n-arylalkanamides.
11416029 - Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing...
3963749 - Acute effects of dietary cod liver oil and cream on plasma lipoproteins.
18052359 - Histidine, lysine, and arginine radical cations: isomer control via the choice of auxil...
2190069 - A novel hypothesis for the psycho-modulating effects of lithium: the role of essential ...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  48     ISSN:  0022-2623     ISO Abbreviation:  J. Med. Chem.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-18     Completed Date:  2005-10-14     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5589-99     Citation Subset:  IM    
Department of Medicinal Chemistry, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065-0900, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antilipemic Agents / chemical synthesis*,  chemistry,  pharmacology
Benzofurans / chemical synthesis*,  chemistry,  pharmacology
Carboxylic Acids / chemical synthesis*,  chemistry,  pharmacology
Cholesterol / blood
Hyperlipidemias / drug therapy
Molecular Conformation
PPAR alpha / agonists*,  genetics
Radioligand Assay
Structure-Activity Relationship
Transcriptional Activation
Triglycerides / blood
Reg. No./Substance:
0/2-ethyl-5-(3-(2-chloro-4-(trifluoromethoxy)phenoxy)propoxy)-2,3-dihydro-1-benzofuran-2-carboxylic acid; 0/Antilipemic Agents; 0/Benzofurans; 0/Carboxylic Acids; 0/PPAR alpha; 0/Triglycerides; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 s...
Next Document:  2-[(Carboxymethyl)sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neopl...